GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (AQSE:SCLP.GB) » Definitions » E10

Scancell Holdings (AQSE:SCLP.GB) E10 : £-0.02 (As of Apr. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Scancell Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Scancell Holdings's adjusted earnings per share data for the fiscal year that ended in Apr. 2024 was £-0.014. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is £-0.02 for the trailing ten years ended in Apr. 2024.

During the past 3 years, the average E10 Growth Rate was -26.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Scancell Holdings was 20.60% per year. The lowest was -26.00% per year. And the median was 20.60% per year.

As of today (2024-12-14), Scancell Holdings's current stock price is £ 0.1125. Scancell Holdings's E10 for the fiscal year that ended in Apr. 2024 was £-0.02. Scancell Holdings's Shiller PE Ratio of today is .


Scancell Holdings E10 Historical Data

The historical data trend for Scancell Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings E10 Chart

Scancell Holdings Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.01 -0.01 -0.02 -0.02

Scancell Holdings Semi-Annual Data
Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - -0.02 - -0.02

Competitive Comparison of Scancell Holdings's E10

For the Biotechnology subindustry, Scancell Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scancell Holdings's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's Shiller PE Ratio falls into.



Scancell Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scancell Holdings's adjusted earnings per share data for the fiscal year that ended in Apr. 2024 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Apr. 2024 (Change)*Current CPI (Apr. 2024)
=-0.014/132.2000*132.2000
=-0.014

Current CPI (Apr. 2024) = 132.2000.

Scancell Holdings Annual Data

per_share_eps CPI Adj_EPS
201504 -0.010 99.900 -0.013
201604 -0.011 100.600 -0.014
201704 -0.013 103.200 -0.017
201804 -0.013 105.500 -0.016
201904 -0.014 107.600 -0.017
202004 -0.012 108.600 -0.015
202104 -0.023 110.400 -0.028
202204 -0.006 119.000 -0.007
202304 -0.015 128.300 -0.015
202404 -0.014 132.200 -0.014

Add all the adjusted EPS together and divide 10 will get our e10.


Scancell Holdings  (AQSE:SCLP.GB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Scancell Holdings E10 Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Scancell Holdings Business Description

Traded in Other Exchanges
Address
Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings Headlines

No Headlines